Core and Group Health

A 9th Circuit panel asked a district court to get more information about why a T-Mobile self-insured plan declined to cover an extra procedure.

The new numbers will affect what some employers owe if employees apply, and get, federal premium subsidies.

Although more than one-third of self-funded employers now cover GLP-1 drugs for weight loss, 31% of this group are considering stopping coverage or are unsure about continuing coverage in the next 12 to 24 months.

The firm sees the astonishingly high cost of "cellular, gene and RNA therapies" — high-tech treatments for conditions like sickle cell disease — as an emerging threat

Dealmaking increased employer plans' childbirth-related hospital bills 3.3% and physician services bills 15%.

A new ethics office filing also shows that Daniel Aronowitz has invested in Cigna, CVS and UnitedHealth.